COM:INTERCEPTPHARMA
Intercept Pharmaceuticals
- Stock
Last Close
18.96
07/11 21:00
Market Cap
794.69M
Beta: -
Volume Today
3.91M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 676.96K - | 2.41M 256.29% | 1.77M 26.47% | 1.14M 35.75% | 2.88M 152.70% | 5.29M 83.85% | 7.79M 47.05% | -30.05M 486.06% | -29.98M 0.26% | 7.54M 125.16% | |
average payables | 2.19M - | 3.16M 44.54% | 3.65M 15.40% | 5.45M 49.23% | 6.84M 25.66% | 9.37M 36.85% | 15.37M 64.12% | 21.78M 41.73% | 21.36M 1.93% | 16.18M 24.25% | |
average receivables | 957.65K - | 1.97M 105.45% | 3.12M 58.78% | 8.01M 156.50% | 15.45M 92.86% | 22.13M 43.22% | 31.87M 43.99% | 39.80M 24.88% | 44.58M 12.03% | 37.24M 16.47% | |
book value per share | 4.57 - | 11.11 143.05% | 25.41 128.76% | 12.77 49.75% | 0.65 94.88% | 0.67 2.76% | 1.63 142.34% | -5.06 410.72% | -5.77 13.97% | 2.75 147.69% | |
capex per share | -0.09 - | -0.22 147.23% | -0.25 12.12% | -0.21 17.79% | -0.41 101.41% | -0.01 98.59% | -0.04 511.69% | -0.12 228.85% | -0.01 89.45% | -0.02 34.86% | |
capex to depreciation | -15.42 - | -10.49 31.98% | -3.51 66.53% | -1.33 62.23% | -2.26 70.37% | -0.04 98.39% | -0.31 750.90% | -1.25 302.39% | -0.13 89.32% | -0.96 619.72% | |
capex to operating cash flow | 0.06 - | 0.05 9.02% | 0.04 31.16% | 0.01 59.29% | 0.04 164.00% | 0.00 98.23% | 0.00 592.03% | 0.02 376.66% | 0.01 58.34% | 0.02 122.46% | |
capex to revenue | -1.00 - | -2.67 165.31% | -2.13 19.96% | -0.20 90.46% | -0.08 61.02% | -0.00 98.83% | -0.00 385.35% | -0.01 176.04% | -0.00 91.22% | -0.00 82.01% | |
cash per share | 8.04 - | 22.10 175.02% | 51.63 133.58% | 54.13 4.84% | 30.33 43.98% | 29.13 3.96% | 20.62 29.22% | 14.25 30.91% | 13.16 7.63% | 14.35 9.05% | |
days of inventory on hand | 926.48 - | 1.03K 11.17% | 733.29 28.80% | -4.70K 741.33% | 1.01K 121.58% | 2.40K 136.20% | |||||
days payables outstanding | 1.85K - | 1.70K 8.07% | 1.64K 3.54% | 1.69K 2.58% | 2.13K 26.57% | 5.28K 147.31% | |||||
days sales outstanding | 310.16 - | 535.77 72.74% | 484.26 9.61% | 180.44 62.74% | 51.76 71.31% | 52.16 0.76% | 55.10 5.65% | 48.50 11.98% | 47.82 1.41% | 34.32 28.23% | |
debt to assets | 0.03 - | 0.04 50.34% | 0.46 - | 0.73 59.03% | 0.89 21.35% | 0.71 19.95% | 0.99 38.97% | 1.04 4.73% | 0.60 42.14% | ||
debt to equity | 0.05 - | 0.04 9.28% | 1.08 - | 21.71 1,902.59% | 23.72 9.27% | 10.45 55.96% | -3.45 133.02% | -2.97 13.76% | 3.57 220.16% | ||
dividend yield | |||||||||||
earnings yield | -0.06 - | -0.09 58.62% | -0.06 26.75% | -0.15 140.77% | -0.25 59.81% | -0.11 56.22% | -0.10 7.51% | -0.40 299.37% | -0.28 29.89% | 0.28 198.58% | |
enterprise value | 1.22B - | 3.00B 146.59% | 2.91B 3.06% | 2.33B 19.89% | 1.40B 39.77% | 2.80B 99.65% | 4.39B 56.60% | 1.33B 69.67% | 982.05M 26.26% | 700.72M 28.65% | |
enterprise value over ebitda | -111.66 - | 52.07 146.63% | -12.85 124.69% | -5.85 54.50% | -4.24 27.48% | -10.06 137.17% | -14.47 43.80% | -6.28 56.62% | -18.32 191.92% | -11.36 38.01% | |
ev to operating cash flow | -43.48 - | -34.22 21.29% | -17.87 47.79% | -6.81 61.89% | -5.29 22.28% | -11.65 120.13% | -18.56 59.31% | -7.83 57.79% | -23.58 201.12% | -26.17 10.94% | |
ev to sales | 750.89 - | 1.72K 129.55% | 1.05K 39.30% | 93.45 91.07% | 10.72 88.52% | 15.59 45.41% | 17.42 11.73% | 4.26 75.56% | 2.70 36.56% | 2.45 9.23% | |
free cash flow per share | -1.64 - | -4.44 170.40% | -7.13 60.31% | -14.09 97.74% | -11.01 21.88% | -8.46 23.12% | -7.51 11.25% | -5.28 29.77% | -1.32 75.01% | -0.81 38.68% | |
free cash flow yield | -0.02 - | -0.03 18.35% | -0.05 67.45% | -0.13 171.82% | -0.19 45.29% | -0.08 55.44% | -0.06 27.81% | -0.21 252.35% | -0.08 62.12% | -0.07 19.24% | |
graham net net | 4.36 - | 21.16 385.01% | 49.49 133.83% | 37.35 24.52% | 12.27 67.14% | 12.71 3.57% | -0.57 104.46% | -8.52 1,402.40% | -7.88 7.50% | 1.43 118.12% | |
graham number | 19.66 - | 58.36 196.79% | 73.92 26.66% | 69.35 6.19% | 14.55 79.02% | 12.82 11.90% | 21.28 66.00% | 33.46 57.27% | 24.29 27.41% | 14.51 40.25% | |
income quality | 0.41 - | 0.31 25.01% | 0.72 132.24% | 0.83 15.30% | 0.74 11.21% | 0.78 5.69% | 0.69 11.81% | 0.62 9.89% | 0.46 26.37% | 0.15 66.37% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -28.36 - | -11.47 59.56% | -9.35 18.42% | -7.59 18.81% | -4.51 40.64% | -1.02 77.27% | -3.19 211.32% | ||||
interest debt per share | 0.23 - | 0.50 120.49% | 14.42 - | 15.36 6.58% | 17.01 10.73% | 18.31 7.64% | 18.91 3.28% | 18.86 0.26% | 10.46 44.53% | ||
inventory turnover | 0.39 - | 0.35 10.05% | 0.50 40.45% | -0.08 115.59% | 0.36 563.42% | 0.15 57.66% | |||||
invested capital | 0.05 - | 0.04 9.28% | 1.08 - | 21.71 1,902.59% | 23.72 9.27% | 10.45 55.96% | -3.45 133.02% | -2.97 13.76% | 3.57 220.16% | ||
market cap | 1.23B - | 3.24B 163.38% | 3.54B 9.14% | 2.68B 24.28% | 1.46B 45.38% | 2.87B 96.01% | 3.92B 36.73% | 814.36M 79.24% | 519.55M 36.20% | 418.56M 19.44% | |
net current asset value | 79.65M - | 222.57M 179.43% | 588.08M 164.22% | 283.54M 51.79% | -19.65M 106.93% | -7.61M 61.27% | 17.98M 336.27% | -270.17M 1,602.21% | -208.69M 22.76% | 79.49M 138.09% | |
net debt to ebitda | 1.23 - | -4.16 439.26% | 2.77 166.72% | 0.87 68.52% | 0.18 79.51% | 0.23 30.16% | -1.54 762.73% | -2.44 57.97% | -8.63 253.88% | -4.57 46.99% | |
net income per share | -3.76 - | -13.63 262.41% | -9.56 29.87% | -16.74 75.16% | -14.38 14.07% | -10.86 24.47% | -12.35 13.71% | -9.83 20.40% | -4.55 53.76% | 3.40 174.86% | |
operating cash flow per share | -1.55 - | -4.22 171.75% | -6.88 62.86% | -13.88 101.95% | -10.59 23.71% | -8.46 20.17% | -7.47 11.61% | -5.16 31.01% | -1.31 74.68% | -0.79 39.38% | |
payables turnover | 0.20 - | 0.21 8.77% | 0.22 3.67% | 0.22 2.51% | 0.17 20.99% | 0.07 59.57% | |||||
receivables turnover | 1.18 - | 0.68 42.11% | 0.75 10.64% | 2.02 168.37% | 7.05 248.59% | 7.00 0.76% | 6.62 5.34% | 7.53 13.61% | 7.63 1.43% | 10.64 39.34% | |
research and ddevelopement to revenue | 17.23 - | 46.10 167.56% | 46.08 0.05% | 6.17 86.61% | 1.46 76.29% | 1.15 21.16% | 0.96 16.43% | 0.61 36.44% | 0.51 16.76% | 0.62 21.29% | |
return on tangible assets | -0.45 - | -1.11 147.10% | -0.35 69.02% | -0.56 61.73% | -0.74 33.23% | -0.61 18.37% | -0.52 14.71% | -0.56 7.82% | -0.28 50.73% | 0.21 175.59% | |
revenue per share | 0.09 - | 0.08 6.82% | 0.12 40.09% | 1.01 761.63% | 5.23 416.66% | 6.32 20.85% | 7.96 26.03% | 9.48 19.13% | 11.40 20.16% | 8.44 25.91% | |
roe | -0.82 - | -1.23 49.11% | -0.38 69.34% | -1.31 248.60% | -21.99 1,577.71% | -16.17 26.50% | -7.58 53.08% | 1.94 125.62% | 0.79 59.43% | 1.24 56.97% | |
roic | -0.65 - | -0.75 16.02% | -0.38 49.12% | -0.63 65.98% | -0.98 53.66% | -0.62 36.73% | -0.59 3.69% | -0.60 1.51% | -0.24 60.44% | 0.11 144.23% | |
sales general and administrative to revenue | 8.10 - | 19.86 145.28% | 37.29 87.74% | 10.97 70.60% | 2.09 80.94% | 1.42 32.02% | |||||
shareholders equity per share | 4.57 - | 11.11 143.05% | 25.41 128.76% | 12.77 49.75% | 0.65 94.88% | 0.67 2.76% | 1.63 142.34% | -5.06 410.72% | -5.77 13.97% | 2.75 147.69% | |
stock based compensation to revenue | 5.83 - | 11.55 98.35% | 12.29 6.37% | 1.85 84.93% | 0.44 76.51% | 0.28 36.19% | 0.22 19.98% | 0.19 12.40% | 0.09 52.09% | 0.08 17.83% | |
tangible asset value | 82.41M - | 230.89M 180.19% | 602.15M 160.79% | 314.93M 47.70% | 16.39M 94.80% | 19.13M 16.75% | 51.56M 169.50% | -166.85M 423.63% | -183.96M 10.25% | 93.08M 150.60% | |
tangible book value per share | 4.57 - | 11.11 143.05% | 25.41 128.76% | 12.77 49.75% | 0.65 94.88% | 0.67 2.76% | 1.63 142.34% | -5.06 410.72% | -5.77 13.97% | 2.75 147.69% | |
working capital | 138.68M - | 230.59M 66.27% | 594.32M 157.74% | 629.35M 5.89% | 344.27M 45.30% | 368.22M 6.96% | 559.31M 51.90% | 298.09M 46.70% | 335.48M 12.54% | 310.05M 7.58% |
All numbers in USD (except ratios and percentages)